PortalPublikationenBiomarker validation of a cued recall memory deficit in prod...

Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.

Standard

Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. / Wagner, M; Wolf, S; Reischies, F M; Daerr, M; Wolfsgruber, S; Jessen, F; Popp, J; Maier, W; Hüll, M; Frölich, L; Hampel, H; Perneczky, R; Peters, O; Jahn, Holger; Luckhaus, C; Gertz, H-J; Schröder, J; Pantel, J; Lewczuk, P; Kornhuber, J; Wiltfang, J.

in: NEUROLOGY, Jahrgang 78, Nr. 6, 6, 2012, S. 379-386.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Wagner, M, Wolf, S, Reischies, FM, Daerr, M, Wolfsgruber, S, Jessen, F, Popp, J, Maier, W, Hüll, M, Frölich, L, Hampel, H, Perneczky, R, Peters, O, Jahn, H, Luckhaus, C, Gertz, H-J, Schröder, J, Pantel, J, Lewczuk, P, Kornhuber, J & Wiltfang, J 2012, 'Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.', NEUROLOGY, Jg. 78, Nr. 6, 6, S. 379-386. <http://www.ncbi.nlm.nih.gov/pubmed/22238414?dopt=Citation>

APA

Wagner, M., Wolf, S., Reischies, F. M., Daerr, M., Wolfsgruber, S., Jessen, F., Popp, J., Maier, W., Hüll, M., Frölich, L., Hampel, H., Perneczky, R., Peters, O., Jahn, H., Luckhaus, C., Gertz, H-J., Schröder, J., Pantel, J., Lewczuk, P., ... Wiltfang, J. (2012). Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. NEUROLOGY, 78(6), 379-386. [6]. http://www.ncbi.nlm.nih.gov/pubmed/22238414?dopt=Citation

Vancouver

Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F et al. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. NEUROLOGY. 2012;78(6):379-386. 6.

Bibtex

@article{0aa952c84a8b49d19ce4e7f6540bd542,
title = "Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.",
abstract = "To compare cued recall measures with other memory and nonmemory tests regarding their association with a biomarker profile indicative of Alzheimer disease (AD) in CSF among patients with mild cognitive impairment (MCI).",
keywords = "Humans, Male, Aged, Female, Middle Aged, Neuropsychological Tests, Disease Progression, Cues, *Mental Recall, Alzheimer Disease/cerebrospinal fluid/psychology, Amyloid beta-Peptides/*cerebrospinal fluid, Mild Cognitive Impairment/*cerebrospinal fluid/psychology, Peptide Fragments/*cerebrospinal fluid, tau Proteins/*cerebrospinal fluid, Humans, Male, Aged, Female, Middle Aged, Neuropsychological Tests, Disease Progression, Cues, *Mental Recall, Alzheimer Disease/cerebrospinal fluid/psychology, Amyloid beta-Peptides/*cerebrospinal fluid, Mild Cognitive Impairment/*cerebrospinal fluid/psychology, Peptide Fragments/*cerebrospinal fluid, tau Proteins/*cerebrospinal fluid",
author = "M Wagner and S Wolf and Reischies, {F M} and M Daerr and S Wolfsgruber and F Jessen and J Popp and W Maier and M H{\"u}ll and L Fr{\"o}lich and H Hampel and R Perneczky and O Peters and Holger Jahn and C Luckhaus and H-J Gertz and J Schr{\"o}der and J Pantel and P Lewczuk and J Kornhuber and J Wiltfang",
year = "2012",
language = "English",
volume = "78",
pages = "379--386",
journal = "NEUROLOGY",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

RIS

TY - JOUR

T1 - Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.

AU - Wagner, M

AU - Wolf, S

AU - Reischies, F M

AU - Daerr, M

AU - Wolfsgruber, S

AU - Jessen, F

AU - Popp, J

AU - Maier, W

AU - Hüll, M

AU - Frölich, L

AU - Hampel, H

AU - Perneczky, R

AU - Peters, O

AU - Jahn, Holger

AU - Luckhaus, C

AU - Gertz, H-J

AU - Schröder, J

AU - Pantel, J

AU - Lewczuk, P

AU - Kornhuber, J

AU - Wiltfang, J

PY - 2012

Y1 - 2012

N2 - To compare cued recall measures with other memory and nonmemory tests regarding their association with a biomarker profile indicative of Alzheimer disease (AD) in CSF among patients with mild cognitive impairment (MCI).

AB - To compare cued recall measures with other memory and nonmemory tests regarding their association with a biomarker profile indicative of Alzheimer disease (AD) in CSF among patients with mild cognitive impairment (MCI).

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Neuropsychological Tests

KW - Disease Progression

KW - Cues

KW - Mental Recall

KW - Alzheimer Disease/cerebrospinal fluid/psychology

KW - Amyloid beta-Peptides/cerebrospinal fluid

KW - Mild Cognitive Impairment/cerebrospinal fluid/psychology

KW - Peptide Fragments/cerebrospinal fluid

KW - tau Proteins/cerebrospinal fluid

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Neuropsychological Tests

KW - Disease Progression

KW - Cues

KW - Mental Recall

KW - Alzheimer Disease/cerebrospinal fluid/psychology

KW - Amyloid beta-Peptides/cerebrospinal fluid

KW - Mild Cognitive Impairment/cerebrospinal fluid/psychology

KW - Peptide Fragments/cerebrospinal fluid

KW - tau Proteins/cerebrospinal fluid

M3 - SCORING: Journal article

VL - 78

SP - 379

EP - 386

JO - NEUROLOGY

JF - NEUROLOGY

SN - 0028-3878

IS - 6

M1 - 6

ER -